Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 2
1998 1
1999 1
2000 1
2001 1
2003 1
2004 1
2014 1
2019 6
2020 2
2021 5
2022 4
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Fluoroquinolones.
O'Donnell JA, Gelone SP. O'Donnell JA, et al. Among authors: gelone sp. Infect Dis Clin North Am. 2000 Jun;14(2):489-513, xi. doi: 10.1016/s0891-5520(05)70260-9. Infect Dis Clin North Am. 2000. PMID: 10829268 Review.
The newer fluoroquinolones.
O'Donnell JA, Gelone SP. O'Donnell JA, et al. Among authors: gelone sp. Infect Dis Clin North Am. 2004 Sep;18(3):691-716, x. doi: 10.1016/j.idc.2004.04.011. Infect Dis Clin North Am. 2004. PMID: 15308282 Review.
Reply to Tang and Lai.
File TM, Gelone SP, Schranz J, Alexander E. File TM, et al. Among authors: gelone sp. Clin Infect Dis. 2020 Sep 12;71(6):1583. doi: 10.1093/cid/ciz1174. Clin Infect Dis. 2020. PMID: 31822883 No abstract available.
Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin.
Paukner S, Goldberg L, Alexander E, Das AF, Heinrich S, Patel P, Moran GJ, Sandrock C, File TM Jr, Vidal JE, Waites KB, Gelone SP, Schranz J. Paukner S, et al. Among authors: gelone sp. J Glob Antimicrob Resist. 2022 Jun;29:434-443. doi: 10.1016/j.jgar.2021.10.021. Epub 2021 Nov 14. J Glob Antimicrob Resist. 2022. PMID: 34788694 Free article. Clinical Trial.
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
Howard-Anderson J, Hamasaki T, Dai W, Collyar D, Rubin D, Nambiar S, Kinamon T, Hill C, Gelone SP, Mariano D, Baba T, Holland TL, Doernberg SB, Chambers HF, Fowler VG, Evans SR, Boucher HW. Howard-Anderson J, et al. Among authors: gelone sp. Clin Infect Dis. 2023 Feb 8;76(3):e1157-e1165. doi: 10.1093/cid/ciac692. Clin Infect Dis. 2023. PMID: 36031403 Free PMC article.
31 results